Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA asks Possis for AngioJet trial details:

This article was originally published in Clinica

Executive Summary

The FDA has asked Possis Medical to supply more details on the statistical methods used in the clinical trials of its AngioJet Rapid Thrombectomy System. The system was submitted for a 510(k) clearance in July and is designed to removed blood clots from vessels throughout the body. Possis is expecting to provide this extra information by mid-November and hopes the FDA will respond within 90 days of its submission.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel